CLINICAL UPDATES · SEASON 1 · EPISODE 11

Living Donor Evaluation: What Donors and Recipients Should Know

Living kidney donation offers the best outcomes in transplantation, and its safety rests on the rigour of donor evaluation. This Clinical Update walks through what the workup involves — medical, surgical, and psychosocial — what the long-term evidence says about donor risk, and what both donors and recipients should understand before proceeding.

By Dr. Mohamed Ibrahim, MD, PhD — Assistant Professor of Medicine, Transplant Nephrology, University of Maryland School of Medicine · Last reviewed: November 2026

MedicalVideos Clinical Updates is an educational series produced with full editorial independence. If an episode is sponsor-funded, that funding is labelled on the episode page and on the series hub.

In short: Living kidney donor evaluation is a staged, independent workup — kidney function, imaging, screening, and psychosocial assessment — designed to protect the donor first. It confirms the donor can live healthily with one kidney, that the kidney suits the recipient, and that the decision is free and informed.

The update

The clinical picture

Living donor evaluation answers three questions: is this person healthy enough to live well with one kidney, is the kidney itself suitable, and is the decision free and informed? The medical workup covers kidney function — measured directly in many centres rather than estimated — blood pressure including out-of-office readings, urine testing, diabetes screening, cardiovascular and cancer screening appropriate to age, infection screening, and cross-sectional imaging of the kidney anatomy and vessels. Psychosocial evaluation is equally structural: motivation, understanding, support at home, financial impact, and freedom from pressure are assessed by a team independent of the recipient's clinicians.

The current landscape

Modern evaluation has become more precise and more protective. Measured GFR has largely replaced estimates for borderline candidates. Genetic testing enters when family history suggests inherited kidney disease — critical when the recipient's disease itself may be heritable. Long-term outcome studies, comparing donors with similarly healthy non-donors, show a small absolute increase in kidney failure risk decades later, concentrated in younger donors and those with affected relatives; honest communication of that evidence is now a defined part of consent. Paired exchange and voucher programs have also changed the landscape, letting an incompatible donor-recipient pair still achieve transplantation through a chain.

In practice

The process is staged so donors can stop at any point: initial screening and blood group, laboratory panel, imaging, then specialist reviews, with an independent donor advocate involved throughout. Absolute and relative contraindications are applied consistently — established kidney disease, uncontrolled hypertension, diabetes with end-organ damage, and active malignancy generally exclude donation. Surgical planning uses the imaging to choose side and approach, usually laparoscopic. Consent is documented after a cooling-off period, and donors are told explicitly that declining, even late, is accepted without consequence and can be shielded from the recipient if they wish.

When to escalate

Escalate — meaning pause and investigate — for any discordant result: kidney function lower than expected for age, imaging showing cysts, stones, or anatomical variants that change surgical planning, or blood-pressure readings that differ between clinic and home monitoring. Psychosocial concerns are escalation triggers too: ambivalence, family pressure, or financial stress must be resolved before proceeding, not after. Post-donation, escalating creatinine, new hypertension, or proteinuria at follow-up moves the donor into nephrology care in their own right.

Common questions

How long does donor evaluation take?

Typically several months from first enquiry to surgery, because testing is staged and includes independent medical, surgical, and psychosocial assessments plus a mandatory reflection period in many programs. Faster pathways exist for urgent recipient situations.

Can a donor change their mind?

Yes, at any point, without giving a reason — and the team will protect that decision, including telling the recipient only that the donor was not suitable if the donor wishes. The evaluation is designed so that withdrawal is always safe and private.

What follow-up does a donor get?

Most donors are followed by the centre for at least the first couple of years, with blood pressure, kidney function, and urine checks; long-term, annual checks with their own doctor are recommended. Registries track donor outcomes to keep the evidence base honest.

Is everyone who volunteers accepted?

No. Evaluation deliberately looks for reasons a donation would be unsafe — significant kidney disease, uncontrolled hypertension or diabetes, certain cancers, and psychosocial concerns can all stop a donation. Being turned down is the system working as intended, protecting the donor.

More in Transplant

Related

Related reading

Sources

This Clinical Update is educational content for clinicians and informed patients. It is not medical advice and does not replace the judgment of the treating team. Drug classes are discussed in general terms only; prescribing decisions, doses, and monitoring belong with the patient's own clinicians. Donor evaluation standards vary by country and centre; acceptance decisions are made by the transplant centre's independent donor team.